chr2-189062866-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2

The NM_000393.5(COL5A2):​c.1976C>T​(p.Pro659Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000312 in 1,613,720 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P659P) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.00036 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 1 hom. )

Consequence

COL5A2
NM_000393.5 missense, splice_region

Scores

3
9
7
Splicing: ADA: 0.9871
1
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:5

Conservation

PhyloP100: 6.57
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), COL5A2. . Gene score misZ 2.4395 (greater than the threshold 3.09). Trascript score misZ 3.3523 (greater than threshold 3.09). GenCC has associacion of gene with Ehlers-Danlos syndrome, classic type, 2, Ehlers-Danlos syndrome, classic type.
BP4
Computational evidence support a benign effect (MetaRNN=0.055262804).
BP6
Variant 2-189062866-G-A is Benign according to our data. Variant chr2-189062866-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 155777.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=4}.
BS2
High AC in GnomAd4 at 54 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
COL5A2NM_000393.5 linkuse as main transcriptc.1976C>T p.Pro659Leu missense_variant, splice_region_variant 29/54 ENST00000374866.9 NP_000384.2 P05997
COL5A2XM_011510573.4 linkuse as main transcriptc.1838C>T p.Pro613Leu missense_variant, splice_region_variant 32/57 XP_011508875.1
COL5A2XM_047443251.1 linkuse as main transcriptc.1838C>T p.Pro613Leu missense_variant, splice_region_variant 34/59 XP_047299207.1
COL5A2XM_047443252.1 linkuse as main transcriptc.1838C>T p.Pro613Leu missense_variant, splice_region_variant 33/58 XP_047299208.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
COL5A2ENST00000374866.9 linkuse as main transcriptc.1976C>T p.Pro659Leu missense_variant, splice_region_variant 29/541 NM_000393.5 ENSP00000364000.3 P05997
COL5A2ENST00000618828.1 linkuse as main transcriptc.815C>T p.Pro272Leu missense_variant, splice_region_variant 22/475 ENSP00000482184.1 A0A087WYX9
COL5A2ENST00000470524.2 linkuse as main transcriptn.82C>T splice_region_variant, non_coding_transcript_exon_variant 2/85

Frequencies

GnomAD3 genomes
AF:
0.000356
AC:
54
AN:
151810
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000726
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00218
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000368
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000498
AC:
125
AN:
250984
Hom.:
0
AF XY:
0.000472
AC XY:
64
AN XY:
135624
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00291
Gnomad NFE exome
AF:
0.000432
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000307
AC:
449
AN:
1461792
Hom.:
1
Cov.:
33
AF XY:
0.000300
AC XY:
218
AN XY:
727194
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.0000895
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00253
Gnomad4 NFE exome
AF:
0.000252
Gnomad4 OTH exome
AF:
0.000397
GnomAD4 genome
AF:
0.000355
AC:
54
AN:
151928
Hom.:
0
Cov.:
32
AF XY:
0.000377
AC XY:
28
AN XY:
74268
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.000197
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00218
Gnomad4 NFE
AF:
0.000368
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000664
Hom.:
0
Bravo
AF:
0.000185
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000478
AC:
58
EpiCase
AF:
0.000327
EpiControl
AF:
0.000178

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingBlueprint GeneticsOct 08, 2015- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 05, 2024Variant summary: COL5A2 c.1976C>T (p.Pro659Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0005 in 250984 control chromosomes. The observed variant frequency is approximately 79.69 fold of the estimated maximal expected allele frequency for a pathogenic variant in COL5A2 causing Ehlers-Danlos Syndrome phenotype (6.3e-06). To our knowledge, no occurrence of c.1976C>T in individuals affected with Ehlers-Danlos Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 155777). Based on the evidence outlined above, the variant was classified as likely benign. -
Ehlers-Danlos syndrome, classic type, 2 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMay 03, 2019- -
Ehlers-Danlos syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenNov 02, 2021- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJun 20, 2024In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32161841, 33161638) -
Connective tissue disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingCenter for Human Genetics, Inc, Center for Human Genetics, IncNov 01, 2016- -
COL5A2-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJul 18, 2020This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsJan 14, 2019This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 30, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.098
T
BayesDel_noAF
Uncertain
0.040
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.67
D;T;D
Eigen
Uncertain
0.26
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.88
.;D;D
M_CAP
Pathogenic
0.32
D
MetaRNN
Benign
0.055
T;T;T
MetaSVM
Pathogenic
1.0
D
MutationAssessor
Benign
1.1
L;.;L
PrimateAI
Uncertain
0.69
T
PROVEAN
Uncertain
-2.9
D;.;.
REVEL
Uncertain
0.56
Sift
Benign
0.090
T;.;.
Sift4G
Benign
0.061
T;T;.
Polyphen
0.99
D;.;D
Vest4
0.55
MVP
0.67
MPC
0.61
ClinPred
0.060
T
GERP RS
4.7
Varity_R
0.11
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
0.99
dbscSNV1_RF
Benign
0.58
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145404046; hg19: chr2-189927592; COSMIC: COSV66407115; API